Copyright
©The Author(s) 2026.
World J Psychiatry. Feb 19, 2026; 16(2): 112819
Published online Feb 19, 2026. doi: 10.5498/wjp.v16.i2.112819
Published online Feb 19, 2026. doi: 10.5498/wjp.v16.i2.112819
Table 1 Comparison of baseline characteristics between the two groups, n (%)
| Characteristics | Electroencephalogram group | Control group | Statistical value | P value |
| Demographic characteristics | ||||
| Age (years) (mean ± SD) | 72.3 ± 5.7 | 71.8 ± 6.1 | t = 0.642 | 0.521 |
| Gender | χ² = 0.039 | 0.843 | ||
| Male | 75 (63.6) | 79 (64.8) | ||
| Female | 43 (36.4) | 43 (35.2) | ||
| Body mass index (kg/m²) (mean ± SD) | 23.5 ± 2.8 | 23.2 ± 3.0 | t = 0.779 | 0.437 |
| Clinical characteristics | ||||
| American Society of Anesthesiologists classification | χ² = 0.415 | 0.520 | ||
| Grade II | 72 (61.0) | 69 (56.6) | ||
| Grade III | 46 (39.0) | 53 (43.4) | ||
| Comorbidities | ||||
| Hypertension | 55 (46.6) | 59 (48.4) | χ² = 0.074 | 0.786 |
| Diabetes | 36 (30.5) | 40 (32.8) | χ² = 0.146 | 0.702 |
| Coronary heart disease | 26 (22.0) | 30 (24.6) | χ² = 0.221 | 0.639 |
| Preoperative laboratory tests | ||||
| Hemoglobin (g/L) (mean ± SD) | 118.5 ± 13.2 | 116.8 ± 14.5 | t = 0.946 | 0.345 |
| Albumin (g/L) (mean ± SD) | 36.8 ± 3.5 | 37.2 ± 3.3 | t = -0.897 | 0.371 |
| Tumor characteristics | ||||
| TNM staging | χ² = 0.378 | 0.828 | ||
| Stage I | 32 (27.1) | 30 (24.6) | ||
| Stage II | 51 (43.2) | 53 (43.4) | ||
| Stage III | 35 (29.7) | 39 (32.0) | ||
| Tumor location | χ² = 0.267 | 0.875 | ||
| Cardia | 28 (23.7) | 31 (25.4) | ||
| Body | 45 (38.1) | 43 (35.2) | ||
| Antrum | 45 (38.1) | 48 (39.3) | ||
| Differentiation degree | χ² = 0.199 | 0.905 | ||
| Well differentiated | 21 (17.8) | 19 (15.6) | ||
| Moderately differentiated | 62 (52.5) | 66 (54.1) | ||
| Poorly differentiated | 35 (29.7) | 37 (30.3) | ||
| Surgery-related | ||||
| Surgical approach | χ² = 0.018 | 0.892 | ||
| Open | 69 (58.5) | 72 (59.0) | ||
| Laparoscopic | 49 (41.5) | 50 (41.0) | ||
| Preoperative assessment | ||||
| PSQI total score (mean ± SD) | 9.8 ± 2.6 | 10.1 ± 2.4 | t = -0.904 | 0.367 |
| PSQI component scores (mean ± SD) | ||||
| Sleep quality | 1.8 ± 0.6 | 1.9 ± 0.5 | t = -0.823 | 0.411 |
| Sleep latency | 1.7 ± 0.7 | 1.8 ± 0.6 | t = -0.736 | 0.463 |
| Sleep duration | 1.6 ± 0.5 | 1.7 ± 0.6 | t = -0.871 | 0.385 |
| Sleep efficiency | 1.5 ± 0.6 | 1.6 ± 0.5 | t = -0.802 | 0.424 |
| Sleep disturbances | 1.9 ± 0.4 | 1.8 ± 0.5 | t = 0.645 | 0.520 |
| Use of sleep medication | 0.5 ± 0.8 | 0.6 ± 0.7 | t = -0.600 | 0.549 |
| Daytime dysfunction | 1.7 ± 0.6 | 1.8 ± 0.5 | t = -0.851 | 0.395 |
| HADS scores (mean ± SD) | ||||
| Anxiety subscale (HADS-A) | 5.8 ± 1.9 | 5.7 ± 2.0 | t = 0.401 | 0.689 |
| Depression subscale (HADS-D) | 6.0 ± 1.8 | 5.9 ± 1.7 | t = 0.444 | 0.657 |
Table 2 Multivariate analysis results for postoperative psychological outcomes
| Variable | Odds ratio | 95%CI | P value |
| Protective factors | |||
| Electroencephalogram-guided individualized anesthesia | 0.56 | 0.41-0.78 | 0.003 |
| Reasonable preoperative psychological preparation | 0.65 | 0.45-0.94 | 0.022 |
| Good postoperative pain control (resting Visual Analog Scale < 4) | 0.74 | 0.53-1.02 | 0.067 |
| Risk factors | |||
| Preoperative psychological factors | |||
| Preoperative Hospital Anxiety and Depression Scale score ≥ 8 | 2.15 | 1.42-3.26 | < 0.001 |
| Preoperative PSQI score ≥ 10 | 1.87 | 1.26-2.78 | 0.002 |
| Individual PSQI components | |||
| Poor sleep efficiency (≤ 75%) | 2.24 | 1.48-3.39 | < 0.001 |
| Frequent sleep disturbances (≥ 2.5 points) | 1.95 | 1.32-2.88 | 0.001 |
| Patient-related factors | |||
| Age ≥ 75 years | 1.43 | 1.02-2.01 | 0.038 |
| American Society of Anesthesiologists III | 1.39 | 0.97-1.98 | 0.072 |
| Intraoperative factors | |||
| Intraoperative hypotension | 1.75 | 1.18-2.61 | 0.006 |
| Operation time > 3 hours | 1.68 | 1.13-2.49 | 0.010 |
| Intraoperative blood loss > 300 mL | 1.52 | 1.06-2.17 | 0.021 |
| Intraoperative temperature < 36.0 °C | 1.46 | 1.05-2.03 | 0.024 |
Table 3 Gradient effect of electroencephalogram-guided anesthesia on postoperative psychological outcomes across sleep disorder severity spectrum, mean ± SD
| Sleep disorder severity | Measure | Electroencephalogram group | Control group | t value | P value |
| Severe | HADS-A | 5.9 ± 1.8 | 8.6 ± 2.1 | -5.32 | < 0.001 |
| HADS-D | 6.4 ± 1.6 | 8.2 ± 1.9 | -4.06 | < 0.001 | |
| HADS total | 12.3 ± 3.1 | 16.8 ± 3.4 | -5.48 | < 0.001 | |
| Moderate | HADS total | 10.7 ± 2.9 | 14.2 ± 3.2 | -5.67 | < 0.001 |
| Mild | HADS-A | 4.5 ± 1.7 | 5.3 ± 1.9 | -2.04 | 0.045 |
| HADS-D | 5.0 ± 1.5 | 6.4 ± 1.7 | -4.03 | < 0.001 | |
| HADS total | 9.5 ± 2.6 | 11.7 ± 2.8 | -3.64 | 0.023 |
Table 4 Comparison of postoperative complications and recovery between electroencephalogram and control groups, n (%)
| Outcome | Electroencephalogram group | Control group | Statistic | P value |
| Postoperative complications | ||||
| Overall complication rate | 38 (32.2) | 59 (48.4) | χ² = 6.72 | 0.010 |
| Postoperative delirium | 10 (8.5) | 21 (17.2) | χ² = 4.31 | 0.038 |
| Duration of delirium (days) (mean ± SD) | 1.7 ± 0.6 | 2.5 ± 0.9 | t = -2.62 | 0.014 |
| Postoperative nausea and vomiting | 30 (25.4) | 46 (37.7) | χ² = 4.27 | 0.039 |
| Number of vomiting episodes (mean ± SD) | 1.3 ± 0.6 | 2.2 ± 1.0 | t = -5.05 | < 0.001 |
| Perioperative hypotension | 16 (13.6) | 30 (24.6) | χ² = 4.85 | 0.028 |
| Pulmonary infection | 6 (5.1) | 15 (12.3) | χ² = 3.92 | 0.048 |
| Wound infection | 7 (5.9) | 9 (7.4) | χ² = 0.19 | 0.659 |
| Urinary tract infection | 4 (3.4) | 7 (5.7) | χ² = 0.76 | 0.384 |
| Pain management | ||||
| POD1 VAS score (at rest) (mean ± SD) | 3.2 ± 1.1 | 3.9 ± 1.3 | t = -4.65 | < 0.001 |
| POD1 VAS score (with movement) (mean ± SD) | 5.1 ± 1.4 | 5.8 ± 1.5 | t = -3.73 | < 0.001 |
| POD2 VAS score (at rest) (mean ± SD) | 2.5 ± 0.9 | 3.0 ± 1.1 | t = -3.89 | < 0.001 |
| POD2 VAS score (with movement) (mean ± SD) | 4.2 ± 1.3 | 4.9 ± 1.4 | t = -4.02 | < 0.001 |
| POD3 VAS score (at rest) (mean ± SD) | 1.9 ± 0.8 | 2.3 ± 1.0 | t = -3.46 | 0.001 |
| POD3 VAS score (with movement) (mean ± SD) | 3.6 ± 1.1 | 4.1 ± 1.2 | t = -3.34 | 0.001 |
| Cumulative analgesic consumption (morphine equivalent mg) (mean ± SD) | 45.3 ± 12.8 | 58.7 ± 16.2 | t = -7.24 | < 0.001 |
| Gastrointestinal recovery | ||||
| Time to first bowel sounds (hours) (mean ± SD) | 46.5 ± 12.8 | 53.2 ± 14.5 | t = -3.82 | < 0.001 |
| Time to first flatus (hours) (mean ± SD) | 62.3 ± 15.6 | 70.8 ± 16.9 | t = -4.04 | < 0.001 |
| Time to first liquid diet (days) (mean ± SD) | 3.5 ± 1.2 | 4.3 ± 1.5 | t = -4.53 | < 0.001 |
| Early ambulation | ||||
| Time to first out-of-bed activity (hours) (mean ± SD) | 26.8 ± 7.6 | 32.5 ± 9.2 | t = -5.21 | < 0.001 |
| 6-minute walking test on POD3 (m) (mean ± SD) | 152.6 ± 45.8 | 128.3 ± 40.6 | t = 4.28 | < 0.001 |
| Hospitalization outcomes | ||||
| Total length of stay (days) (mean ± SD) | 12.6 ± 3.2 | 14.8 ± 3.5 | t = -5.05 | 0.012 |
| Postoperative length of stay (days) (mean ± SD) | 10.8 ± 2.7 | 12.5 ± 3.0 | t = -4.58 | < 0.001 |
| 30-day readmission rate | 4 (3.4) | 8 (6.6) | χ² = 1.29 | 0.256 |
- Citation: Zhang XM, Yuan L, Chen YL, Shuai SC, Ye XM, Zhao JB. Electroencephalogram-guided anesthesia and postoperative anxiety and depression in elderly gastric cancer patients with sleep disorders. World J Psychiatry 2026; 16(2): 112819
- URL: https://www.wjgnet.com/2220-3206/full/v16/i2/112819.htm
- DOI: https://dx.doi.org/10.5498/wjp.v16.i2.112819
